Angiotensin-converting enzyme: serum levels during normal pregnancy.

Area of Science:

• Biochemistry
• Physiology
• Reproductive Medicine

Background:

• Angiotensin-converting enzyme (ACE) plays a crucial role in the renin-angiotensin system, influencing blood pressure regulation.
• Changes in ACE activity during pregnancy are not well-established, particularly in peripheral blood serum.
• Understanding ACE levels during gestation is important for monitoring cardiovascular health in pregnant individuals.

Purpose of the Study:

• To investigate the activity of serum ACE in normal pregnancy across different trimesters.
• To determine if pregnancy significantly alters peripheral blood serum ACE levels.
• To compare ACE activity in pregnant women to reported levels in non-pregnant individuals.

Main Methods:

• Serum samples were collected from 52 normal pregnant women across the first, second, and third trimesters.
• In vitro ACE activity was measured using a fluorimetric assay with Hip-His-Leu as the substrate.
• ACE activity was quantified as nmol/min/ml serum and analyzed with respect to serum volume and protein content.

Main Results:

• Serum ACE activity was measured at 30.6 +/- 7.8, 28.8 +/- 7.4, and 30.9 +/- 8.2 nmol/min/ml for the first, second, and third trimesters, respectively.
• No statistically significant differences in ACE activity were observed among the three trimesters of pregnancy (p > 0.05).
• ACE activity levels in pregnant women were comparable to those reported for healthy non-pregnant donors.

Conclusions:

• Normal pregnancy does not significantly alter peripheral blood serum ACE activity.
• The progression of pregnancy does not induce significant changes in circulating ACE levels.
• These findings suggest ACE levels are relatively constant during uncomplicated gestation.